Targeted focal therapy (TFT) in carefully selected patients is a feasible and practical option for treating low-risk prostate cancer (PCa) with minimal impact on quality of life, researchers concluded. Read the article.
Focal Prostate Cancer Therapy Safe, Feasible Read More »
Minimally invasive approach is promising for low-risk disease; outcomes data are lacking. Read the article.
Focal Therapy: Magic Bullet or Unproven Treatment Read More »
If you or someone close to you has lived with prostate cancer, you’ve probably come across dozens of emerging treatments in your hours of Googling. One such treatment, focal therapy, has been dubbed the “new pain-free treatment for prostate cancer”. But don’t hold your breath; it’s still in its experimental phases. This is a warning that focal therapy is still experimental and should be considered only in a clinical trial setting. Read the article.
Focal Therapy – New pain-free treatment for prostate cancer? Not quite Read More »
Laser ablation, cryotherapy, and hemiablative brachytherapy are among the novel approaches that show promise for the focal treatment of localized prostate cancer (PCa), according to studies presented at the 28th annual congress of the European Association of Urology. Most of these treatments are performed under magnetic resonance imaging (MRI) guidance. Read the article.
Focal Therapy for Prostate Cancer Advances Read More »
Men with low-risk prostate cancer who previously had to choose between aggressive treatment, with the potential for significant side effects, and active surveillance, with the risk of disease progression, may have a new option. Focal laser ablation uses precisely targeted heat, delivered through a small insertion and guided into the prostate by magnetic resonance imaging, to burn away cancerous cells in the prostate. Read the article.
Focal Therapy Offers Middle Ground for Some Prostate Cancer Patients Read More »
January 2013 Scotiabank Awateness Night Dr.Laurence Klotz, MD, FRCSC Professor, Department of Surgery, University of Toronto Chief, Division of Urology, Sunnybrook Health Sciences Centre Chair, Canadian Uro-Oncology Group and NCIC GU Site Group Editor in Chief (founding), Canadian Journal of Urology Chair, Global GU Oncology Group For localized prostate cancer, the choice of treatment is becoming less straightforward as preferences shift to less aggressive, less intrusive, and increasingly sophisticated approaches. This presentation provides guidance and insight…with focus on active surveillance, focal therapy, MRI imaging, and recent developments in surgery. CLICK ON THE ARROW TO START THE VIDEO “Navigating treatment
VIDEO: Dr. Laurence Klotz, “Navigating treatment options for localized prostate cancer” Read More »
Dr. Uri Lindner MD, FRCSC Uro-Oncology Fellow Princess Margaret Cancer Centre Toronto, ON, Canada Dr. Lindner is an associate of Dr. John Trachtenberg who has developed a ground-breaking approach to the treatment of prostate cancer. In general approach, this procedure has some similarities to a lumpectomy in the treatment of breast cancer. Despite its recent emergence as an option for treating prostate cancer, MR-guided laser focal therapy for prostate cancer is already earning international attention and attracting increasing interest. CLICK ON THE ARROW TO START THE VIDEO Complete Presentation “MR-guided Laser Focal Therapy for Prostate Cancer.” High Definition 35
VIDEO: Dr. Uri Lindner “MR-guided Laser Focal Therapy for Prostate Cancer.” Read More »
It is hoped the new treatment, which involves heating only the tumours with a highly focused ultrasound, will mean men can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies. Read more.